New tool measures MS brain changes in old hospital scans

Credibility

Interest

Share:1 min read

Key Takeaway

A new tool measured MS lesions and brain shrinkage using older hospital brain scans.

What They Found

Researchers built a tool that measures brain regions and lesions from a single brain scan. They trained it on 4,247 scans from 2,934 people with MS. They then tested it on 14,952 scans from 1,001 people in trials and routine care. It measured lesion size more accurately than two other tools when compared with measurements made by experts. In trial scans, it detected treatment-related differences in new lesions and brain shrinkage.

Who Should Care and Why

The study used scans from people with MS, including people in trials for primary progressive and secondary progressive MS. It also included scans collected during routine MS care. Many older hospital scans lack the types of images usually needed for detailed measurements. This tool was designed to measure brain changes from those single-image scans. In routine-care scans, lesion volume rose with moderately effective treatment but stayed stable with highly effective treatment.

Important Considerations

You should know this was a tool-development study, not a test of a specific MS drug. Researchers trained the tool with scans from 2,934 people and tested it with scans from 1,001 others. The abstract does not say whether using the tool improved anyone’s care.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News